| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/NBT0502-478 |
| P698 | PubMed publication ID | 11981561 |
| P2093 | author name string | Maria D F S Barbosa | |
| David L Pompliano | |||
| Christine F Sizemore | |||
| Lorie A Foster | |||
| Jonathan A Mills | |||
| Joseph A DeVito | |||
| Maria Grazia Cappiello | |||
| Anjana Agarwal | |||
| Zhongjie Yao | |||
| Daniel M Stoughton | |||
| Veronica G Liu | |||
| P2860 | cites work | Lateral gene transfer and the nature of bacterial innovation | Q22122396 |
| Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter | Q27860697 | ||
| An efficient recombination system for chromosome engineering in Escherichia coli | Q29615038 | ||
| A new logic for DNA engineering using recombination in Escherichia coli | Q29615202 | ||
| Cloning and sequencing of Escherichia coli murZ and purification of its product, a UDP-N-acetylglucosamine enolpyruvyl transferase | Q33202551 | ||
| Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor | Q33890948 | ||
| Regulation of the L-arabinose operon of Escherichia coli | Q33927032 | ||
| Kirromycin, an inhibitor of protein biosynthesis that acts on elongation factor Tu | Q34052085 | ||
| Antimicrobial use and bacterial resistance | Q34069797 | ||
| Selective pressure by antibiotic use in livestock | Q34117814 | ||
| Finding drug targets in microbial genomes | Q34346637 | ||
| Bacteriophage P1 cre gene and its regulatory region. Evidence for multiple promoters and for regulation by DNA methylation | Q34688873 | ||
| P1 site-specific recombination: nucleotide sequence of the recombining sites | Q34714015 | ||
| Peptide deformylase as an antibacterial drug target: target validation and resistance development | Q39476838 | ||
| Use of bacteriophage lambda recombination functions to promote gene replacement in Escherichia coli | Q39565526 | ||
| Discovery and development of new antibiotics: the problem of antibiotic resistance | Q39865095 | ||
| Lambda Gam protein inhibits the helicase and chi-stimulated recombination activities of Escherichia coli RecBCD enzyme | Q39943196 | ||
| Broad spectrum antimicrobial biocides target the FabI component of fatty acid synthesis | Q42538502 | ||
| Linezolid resistance in a clinical isolate of Staphylococcus aureus | Q43690311 | ||
| A genome-based approach for the identification of essential bacterial genes. | Q52531899 | ||
| Why are there no new antibiotics? | Q53852776 | ||
| Characterization of a Cys115 to Asp substitution in the Escherichia coli cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl transferase (MurA) that confers resistance to inactivation by the antibiotic fosfomycin. | Q54590227 | ||
| Mutations in a new chromosomal gene of Escherichia coli K-12, pcnB, reduce plasmid copy number of pBR322 and its derivatives. | Q54773863 | ||
| Studies on the properties of P1 site-specific recombination: Evidence for topologically unlinked products following recombination | Q72781777 | ||
| Novel approaches to the discovery of antimicrobial agents | Q77297332 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 478-483 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | Nature Biotechnology | Q1893837 |
| P1476 | title | An array of target-specific screening strains for antibacterial discovery | |
| P478 | volume | 20 |
| Q42647502 | A novel inhibitor that suspends the induced fit mechanism of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA). |
| Q36172371 | A whole-cell phenotypic screening platform for identifying methylerythritol phosphate pathway-selective inhibitors as novel antibacterial agents |
| Q28547068 | An IPTG Inducible Conditional Expression System for Mycobacteria |
| Q38505082 | An array of Escherichia coli clones over-expressing essential proteins: a new strategy of identifying cellular targets of potent antibacterial compounds |
| Q38840796 | An update on the use of C. elegans for preclinical drug discovery: screening and identifying anti-infective drugs |
| Q33768891 | Antibiotic sensitivity profiles determined with an Escherichia coli gene knockout collection: generating an antibiotic bar code |
| Q35207247 | Antifungal and cytotoxicity activities of the fresh xylem sap of Hymenaea courbaril L. and its major constituent fisetin |
| Q39024963 | Assessing the essentiality of the decaprenyl-phospho-d-arabinofuranose pathway in Mycobacterium tuberculosis using conditional mutants |
| Q26765868 | Breaking the Spell: Combating Multidrug Resistant 'Superbugs' |
| Q34579744 | Burkholderia cenocepacia conditional growth mutant library created by random promoter replacement of essential genes |
| Q33793074 | Challenges of antibacterial discovery |
| Q83677579 | Chapter 1. Approaches to discovering novel antibacterial and antifungal agents |
| Q43182308 | Characterization and use of catabolite-repressed promoters from gluconate genes in Corynebacterium glutamicum. |
| Q40763518 | Conditional lethal amber mutations in essential Escherichia coli genes |
| Q33239546 | Conserved fungal genes as potential targets for broad-spectrum antifungal drug discovery |
| Q24802513 | Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor |
| Q34555735 | Cysteinyl-tRNA(Cys) formation in Methanocaldococcus jannaschii: the mechanism is still unknown |
| Q37081699 | Cytoplasmic steps of peptidoglycan biosynthesis |
| Q112647788 | Deep learning-driven prediction of drug mechanism of action from large-scale chemical-genetic interaction profiles |
| Q36845531 | Determination of antibiotic hypersensitivity among 4,000 single-gene-knockout mutants of Escherichia coli |
| Q29547723 | Drugs for bad bugs: confronting the challenges of antibacterial discovery |
| Q36182276 | Functional genomics in antibacterial drug discovery |
| Q35795582 | Genetic Approaches to Facilitate Antibacterial Drug Development |
| Q35140832 | Genetic strategies for antibacterial drug discovery |
| Q38195069 | Genomic tools to profile antibiotic mode of action. |
| Q34315832 | Identification and characterization of inhibitors of bacterial enoyl-acyl carrier protein reductase |
| Q40431670 | Identification of antibiotic stress-inducible promoters: a systematic approach to novel pathway-specific reporter assays for antibacterial drug discovery |
| Q34987387 | Imaging optical sensor arrays |
| Q102075548 | Improving target assessment in biomedical research: the GOT-IT recommendations |
| Q43260897 | Localization of the Bacillus subtilis murB gene within the dcw cluster is important for growth and sporulation. |
| Q44275373 | Locally delivered polyclonal antibodies potentiate intravenous antibiotic efficacy against gram-negative infections |
| Q28388477 | New insights into TB physiology suggest untapped therapeutic opportunities |
| Q37939707 | Overview of anti-infective drug development |
| Q37939709 | Overview of antibacterial target selection |
| Q35128095 | Paired termini stabilize antisense RNAs and enhance conditional gene silencing in Escherichia coli |
| Q34355038 | Pathway-selective sensitization of Mycobacterium tuberculosis for target-based whole-cell screening |
| Q28273315 | Preclinical evaluation of novel antibacterial agents by microbiological and molecular techniques |
| Q51529913 | Real-time image processing for label-free enrichment of Actinobacteria cultivated in picolitre droplets. |
| Q43053415 | Recombineering with tolC as a selectable/counter-selectable marker: remodeling the rRNA operons of Escherichia coli |
| Q35022482 | Reverse engineering gene networks: Integrating genetic perturbations with dynamical modeling |
| Q37912224 | Screening strategies for discovery of antibacterial natural products |
| Q35889596 | Seeing is believing: the impact of structural genomics on antimicrobial drug discovery |
| Q36054436 | Small molecules with antimicrobial activity against E. coli and P. aeruginosa identified by high-throughput screening |
| Q41835213 | Staphylococcus aureus TargetArray: comprehensive differential essential gene expression as a mechanistic tool to profile antibacterials. |
| Q41338706 | Staphylococcus aureus cell wall stress stimulon gene-lacZ fusion strains: potential for use in screening for cell wall-active antimicrobials |
| Q38710256 | Strategies for target identification of antimicrobial natural products |
| Q30332062 | Structural proteomics: the potential of high-throughput structure determination. |
| Q30393244 | Target-based identification of whole-cell active inhibitors of biotin biosynthesis in Mycobacterium tuberculosis |
| Q42015300 | Target-based whole-cell screening by ¹H NMR spectroscopy |
| Q26795478 | The application of tetracyclineregulated gene expression systems in the validation of novel drug targets in Mycobacterium tuberculosis |
| Q49988467 | The challenge of converting Gram-positive-only compounds into broad-spectrum antibiotics |
| Q50044505 | The controlled in vitro susceptibility of gastrointestinal pathogens to the antibacterial effect of manuka honey |
| Q35428115 | Tunable protein degradation in bacteria |
| Q42839659 | Utilization of target-specific, hypersensitive strains of Saccharomyces cerevisiae to determine the mode of action of antifungal compounds |
Search more.